Practice Variation on Antithrombotics in COVID-19
Current Practices on Antithrombotic Therapy in Hospitalised and Discharged Patients With COVID-19
Current Practices on Antithrombotic Therapy in Hospitalised and Discharged Patients With COVID-19
Sponsor study identifier
observational
435
1 country
1
Study Start
October 1, 2021
Actual (reported)Primary Completion
October 30, 2021
Actual (reported)Study Completion
November 10, 2021
Actual (reported)Evidence suggests coronavirus disease 2019 (COVID-19) is associated with an increased incidence of thromboembolic manifestations. Various guidelines on managing antithrombotics in COVID-19 either provided conflicting guidance or unclear recommendations for post-discharge thromboprophylaxis. The investigators aim to collect the current practices in India among physicians on antithrombotic therapy for hospitalised patients with COVID-19 and after discharge from the hospital.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
November 10, 2021
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
August 8, 2021
Actual (reported)August 10, 2021
Actual (reported)October 1, 2021
Actual (reported)October 30, 2021
Actual (reported)November 10, 2021
Actual (reported)Choice, dose, and indication of antithrombotics for management of COVID-19.
Through web-based cross-sectional survey will capture the practices of physicians on choice, dose, and indication of antithrombotics for management of COVID-19 during hospitalisation and post-discharge
two weeks
Current clinical practice of participating physicians on management of antithrombotics for COVID-19 during hospitalisation and post-discharge
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Physicians from different specialities like Internal Medicine, Pulmonary Medicine, Anesthesiologists, Critical Care Medicine will be recruited through snowballing sampling. A web-based cross-sectional survey will be circulated among the target population by the investigators through e-mail and social media channels.
Reliance Hospital
Mumbai, Mumbai, Mahrastra, India
Chandra A, Chakraborty U, Ghosh S, Dasgupta S. Anticoagulation in COVID-19: current concepts and controversies. Postgrad Med J. 2022 May;98(1159):395-402. doi: 10.1136/postgradmedj-2021-139923. Epub 2021 Apr 13.
Fontelo P, Bastola MM, Zheng Z, Baik SH. A review of thromboembolic events in hospitalized COVID-19 patients. Thromb J. 2021 Jun 29;19(1):47. doi: 10.1186/s12959-021-00298-3.
Jagiasi B, Nasa P, Chanchalani G, Ahmed A, Ak AK, Sodhi K, Mangal K, Singh MK, Gupta N, Bidkar PU, Tyagi RS, Khanikar RG, Tripathy S, Khanzode S, Subba Reddy K, Saigal S, Sivakumar VA, Javeri Y, Tekwani SS. Variation in therapeutic strategies for the management of severe COVID-19 in India: A nationwide cross-sectional survey. Int J Clin Pract. 2021 Oct;75(10):e14574. doi: 10.1111/ijcp.14574. Epub 2021 Jul 18.
Prashant Nasa, MD EDICM
NMC Specialty Hospital, Dubai, UAE
435 participants (actual enrollment reported by the registry).
First Submitted
August 8, 2021
First Posted
August 10, 2021
Study Start
October 1, 2021
Actual (reported)Effect of Slope Time in PCV Mode on Mechanical Power Calculation and Oxygenation in Covid-19 ARDS Patients.
Contact the study team to confirm eligibility.
Liu Y, Cai J, Wang C, Jin J, Qu L. A systematic review and meta-analysis of incidence, prognosis, and laboratory indicators of venous thromboembolism in hospitalized patients with coronavirus disease 2019. J Vasc Surg Venous Lymphat Disord. 2021 Sep;9(5):1099-1111.e6. doi: 10.1016/j.jvsv.2021.01.012. Epub 2021 Jan 30.
Primary Completion
October 30, 2021
Actual (reported)Study Completion
November 10, 2021
Actual (reported)Last Updated
November 24, 2021
Record last verified: 2021-11
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: